November 21, 2022
Today, the U.S. Food and Drug Administration (FDA) posted warning letters to five companies for illegally selling products containing cannabidiol (CBD).
Warning letters were sent to the following companies:
These companies are selling CBD containing products that people may confuse for traditional foods or beverages which may result in unintentional consumption or overconsumption of CBD. CBD-containing products in forms that are appealing to children, such as gummies, hard candies and cookies, are especially concerning.
The use of CBD raises safety concerns, especially with long-term use. Risks include liver injury, harm to the male reproductive system, and side effects, such as changes in alertness and other symptoms. The FDA has not found adequate information showing how much CBD can be consumed, and for how long, before causing harm. This is particularly true for vulnerable populations like children and those who are pregnant. People should be aware of the potential risks associated with the use of CBD products.
FDA experts commented on the agency’s concerns with adding CBD to food and on information they want consumers to know. View the conversation on our website.
Today’s warning letters also outline additional violations of the FD&C Act, including that several of the companies are illegally selling unapproved CBD products that claim to cure, mitigate, treat or prevent various diseases, and adding CBD to animal foods, such as pet treats.
The FDA has requested responses from the companies within 15 working days stating how they will address the issues described in the warning letters or providing their reasoning and supporting information as to why they think the products are not in violation of the law. Failure to adequately address the violations promptly may result in legal action, including product seizure and/or injunction.
Continue at FDA website
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link